India's parliamentary committee criticized the drug pricing regulator for approving a 50% price increase on 11 drug ...

It's been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Viking Therapeutics' leading ...

Dr. Karim Seghir, Chancellor of Ajman University, lauded this achievement, stating: “Prof. Sai Boddu’s recognition as a ...

Telangana DCA seizes ₹2 crore worth of illegally manufactured drugs from Akron Formulations India Private Limited in ...

Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s ...

Structure Therapeutics has a strong cash position with a runway of 18-20 quarters, but the drug's potential is not fully ...

One could be forgiven for feeling the same way about the current world of drug delivery devices, with an increasingly ...

Topiramate is under development for the treatment of obesity, epilepsy and migrane. The drug candidate is administered intravenously, oral and intramuscularly. It is developed using an advanced drug ...

After reinvigorating a decades-old schizophrenia drug in an innovative long-acting treatment option, Teva is looking to ...

Anlon Healthcare is a chemical manufacturing company engaged in manufacturing of high purity advance pharmaceutical ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

Novartis reported that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) reached its primary endpoint in a Phase III study in paediatric patients aged two to 17 with type II ...